Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial to Investigate the Appropriate Dose of Isoniazid According to NAT2 Polymorphism Status in Korean Subjects

NCT03665402 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03665402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03665402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial to Investigate the Appropriate Dose of Isoniazid According to NAT2 Polymorphism Status in Korean Subjects
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 13, 2018
Completion date
March 31, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, drug-induced liver injury, tuberculosis